Your search returned 3 results.

Results
	1.	A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. [electronic resource] by Swaney, J S Chapman, C Correa, L D Stebbins, K J Bundey, R A Prodanovich, P C Fagan, P Baccei, C S Santini, A M Hutchinson, J H Seiders, T J Parr, T A Prasit, P Evans, J F Lorrain, D S Producer: 20101130 In: British journal of pharmacology vol. 160 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP). [electronic resource] by Bain, G King, C D Rewolinski, M Schaab, K Santini, A M Shapiro, D Moran, M van de Wetering de Rooij, S Roffel, A F Schuilenga-Hut, P Milne, G L Lorrain, D S Li, Y Arruda, J M Hutchinson, J H Prasit, P Evans, J F Producer: 20100416 In: Clinical pharmacology and therapeutics vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. [electronic resource] by Swaney, J S Chapman, C Correa, L D Stebbins, K J Broadhead, A R Bain, G Santini, A M Darlington, J King, C D Baccei, C S Lee, C Parr, T A Roppe, J R Seiders, T J Ziff, J Prasit, P Hutchinson, J H Evans, J F Lorrain, D S Producer: 20110421 In: The Journal of pharmacology and experimental therapeutics vol. 336 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)